Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A1 | Q13285 | 1/20 | 0.65 |
| ▸ | LTA4H | P09960 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 7/20 | 0.56 |
| ▸ | NPC1 | O15118 | 6/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | RARB | P10826 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | STAT3 | P40763 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6976554 | 1.00 | NR5A1 (0.65) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL6980107 | 1.00 | NR5A1 (0.65) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL10346198 | 1.00 | NR5A1 (0.65) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL8387949 | 1.00 | NR5A1 (0.65) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL7061013 | 1.00 | NR5A1 (0.65) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL7865004 | 0.98 | NR5A1 (0.63) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL8436081 | 0.98 | NR5A1 (0.63) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL7089844 | 0.98 | NR5A1 (0.62) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL9228047 | 0.90 | NR5A1 (0.69) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL6255603 | 0.90 | NR5A1 (0.69) | NR5A1LTA4HRAB9ANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0549279-B1 | Optically active pyrimidine compound, process for producing the same and liquid crystal composition containing the same | SUMITOMO CHEMICAL CO (JP) | 2000-03-29 | — | — | EP | claimed |
| US-5326871-A | Optically active pyrimidine compound, process for producing the same and liquid crystal composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-07-05 | — | — | US | claimed |
| EP-0549279-A1 | Optically active pyrimidine compound, process for producing the same and liquid crystal composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-06-30 | — | — | EP | claimed |
| JP-5247000-A | — | — | None | — | — | JP | disclosed |
| JP-3264566-A | — | — | None | — | — | JP | disclosed |
| US-7468198-B2 | Liquid crystal compound, ferroelectric liquid crystal composition, and ferroelectric liquid crystal display | DAI NIPPON PRINTING CO. LTD. (JP) | 2008-12-23 | — | — | US | disclosed |
| US-20080230745-A1 | LIQUID CRYSTAL COMPOUND, FERROELECTRIC LIQUID CRYSTAL COMPOSITION, AND FERROELECTRIC LIQUID CRYSTAL DISPLAY | DAI NIPPON PRINTING CO., LTD. (JP) | 2008-09-25 | — | — | US | disclosed |
| US-6783812-B2 | USEFUL IN THE MANUFACTURE OF OPTICAL DEVICES; STABILITY | DISPLAYTECH, INC. | 2004-08-31 | — | — | US | disclosed |
| US-6737124-B2 | ESPECIALLY DISILANES | DISPLAYTECH, INC. | 2004-05-18 | — | — | US | disclosed |
| US-20030003245-A1 | Liquid crystal compounds having a silane tail with a perfluoroalkyl terminal portion | CITIZEN FINETECH MIYOTA CO., LTD. (JP) | 2003-01-02 | — | — | US | disclosed |
| US-20020130299-A1 | Alkyl silane liquid crystal compounds | CITIZEN FINEDEVICE CO., LTD. (JP) | 2002-09-19 | — | — | US | disclosed |
| EP-0606090-A1 | Mesomorphic compound, liquid crystal composition containing same, and liquid crystal device using same | CANON KABUSHIKI KAISHA (JP) | 1994-07-13 | — | — | EP | disclosed |
| US-5326871-A | Optically active pyrimidine compound, process for producing the same and liquid crystal composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-07-05 | — | — | US | disclosed |
| EP-0582489-A1 | Ferroelectric liquid crystal compounds with cyclohexenyl cores and compositions containing them | DISPLAYTECH, INCORPORATED (US) | 1994-02-09 | — | — | EP | disclosed |
| US-5271864-A | Ferroelectric liquid crystal compounds with cyclohexenyl cores and compositions containing them | DISPLAYTECH, INC. (US) | 1993-12-21 | — | — | US | disclosed |
| JP-H05247000-A | OPTICALLY ACTIVE PYRIMIDINE COMPOUND, ITS PRODUCTION AND LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEM CO LTD | 1993-09-24 | — | — | JP | disclosed |
| EP-0549279-A1 | Optically active pyrimidine compound, process for producing the same and liquid crystal composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-06-30 | — | — | EP | disclosed |
| JP-H03264566-A | OPTICALLY ACTIVE ALCOHOLS AND PRODUCTION THEREOF | SUMITOMO CHEM CO LTD | 1991-11-25 | — | — | JP | disclosed |
| EP-0360622-A2 | Novel optically active benzene derivatives, process for producing the same and liquid-crystalline composition containing said derivatives as liquid-crystalline compound and light switching elements | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-03-28 | — | — | EP | disclosed |
| EP-0225195-A1 | Phenylpyrimidine-based compounds and liquid crystal composition containing the same | AJINOMOTO CO., INC. (JP) | 1987-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030003245-A1 | Liquid crystal compounds having a silane tail with a perfluoroalkyl terminal portion | FFAR3, FFAR1, LPAR1 | NR5A1 379/4885LTA4H 1475/4885RAB9A 1832/4885 |
| US-20080230745-A1 | LIQUID CRYSTAL COMPOUND, FERROELECTRIC LIQUID CRYSTAL COMPOSITION, AND FERROELECTRIC LIQUID CRYSTAL DISPLAY | CXCR6, CXCR1, SFXN1 | NR5A1 1173/4885LTA4H 1570/4885RAB9A 1534/4885 |
| US-20020130299-A1 | Alkyl silane liquid crystal compounds | SMURF1, SMURF2, DSTN | NR5A1 2749/4885LTA4H 1301/4885RAB9A 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.